Author details

Full Name

William F Owen

Affiliation

ORCID

Career Start Year

1951

Papers

147

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
22549607	Perspectives on humanism in medicine from the 2012 Edward J. III Excellence in Medicine honorees.	MD Advis	2012
21051598	The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.	Science	2010
19245692	Hypertension Improvement Project (HIP): study protocol and implementation challenges.	Trials	2009
17391130	Predialysis nephrologist care and access to kidney transplantation in the United States.	American Journal of Transplantation	2007
17500426	Relationship between nephrologist care and progression of chronic kidney disease.	N C Med J	2007
16732194	Associations between CMS's Clinical Performance Measures project benchmarks, profit structure, and mortality in dialysis units.	Kidney Int	2006
16797400	Surrogate markers in clinical studies: problems solved or created?	American Journal of Kidney Diseases	2006
16192421	Association of achieved dialysis dose with mortality in the hemodialysis study: an example of "dose-targeting bias".	Journal of the American Society of Nephrology : JASN	2005
15930095	Intradialytic blood volume monitoring in ambulatory hemodialysis patients: a randomized trial.	J Am Soc Nephrol	2005
15708102	Aseptic peritonitis due to peptidoglycan contamination of pharmacopoeia standard dialysis solution.	Lancet, The	2005
15213278	Enhanced expression of receptor for advanced glycation end products in chronic kidney disease.	Journal of the American Society of Nephrology : JASN	2004
15504950	Inequality in quality: are patient health activation and CQI corrective approaches?	Journal of the American Society of Nephrology : JASN	2004
15327423	A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United States.	Kidney International	2004
15308993	Slowing the progression of diabetic nephropathy and its cardiovascular consequences.	Am Heart J	2004
15458473	Regarding impact of epoetin alfa on clinical end points in patients with chronic renal failure: a meta-analysis.	Kidney International	2004
15086479	Dialysis dose and the effect of gender and body size on outcome in the HEMO Study.	Kidney International	2004
12937316	Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease.	J Am Soc Nephrol	2003
19379340	Toward a continuous quality improvement paradigm for hemodialysis providers with preliminary suggestions for clinical practice monitoring and measurement.	Hemodialysis International	2003
12505565	Treatment effects of eptifibatide in planned coronary stent implantation in patients with chronic kidney disease (ESPRIT Trial).	Am J Cardiol	2003
12480973	Regional variability in anaemia management and haemoglobin in the US.	Nephrol Dial Transplant	2003
12538751	A propensity analysis of late versus early nephrologist referral and mortality on dialysis.	Journal of the American Society of Nephrology : JASN	2003
12748351	White blood cells as a novel mortality predictor in haemodialysis patients.	Nephrol Dial Transplant	2003
14605267	Left ventricular hypertrophy: a surrogate end point or correlate of cardiovascular events in kidney disease?	Nephrology Dialysis Transplantation	2003
14520632	Developing clinical performance measures based on the Dialysis Outcomes Quality Initiative Clinical Practice Guidelines: process, outcomes, and implications.	Am J Kidney Dis	2003
12787422	The cost-effectiveness of maintaining higher hemoglobin targets with erythropoietin in hemodialysis patients.	Kidney International	2003
12897099	Interactions between dialysis-related volume exposures, nutritional surrogates and mortality among ESRD patients.	Nephrol Dial Transplant	2003
12819307	Patterns of care for patients with chronic kidney disease in the United States: dying for improvement.	Journal of the American Society of Nephrology : JASN	2003
11911757	Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis.	JAMA	2002
12105392	Beta 2-microglobulin amyloidosis: role of monocytes/macrophages.	Current Opinion in Nephrology and Hypertension	2002
12100461	Study designs and their potential influence on conclusions.	Semin Dial	2002
12040000	Perception versus reality of the burden of chronic kidney disease in the United States.	Journal of the American Society of Nephrology : JASN	2002
12230424	Nephrologist care and mortality in patients with chronic renal insufficiency.		2002
11961018	Receptor for advanced glycation end products on human synovial fibroblasts: role in the pathogenesis of dialysis-related amyloidosis.	Journal of the American Society of Nephrology : JASN	2002
11961017	Trends in anemia management among US hemodialysis patients.	J Am Soc Nephrol	2002
11893342	Potential cost savings of erythropoietin administration in end-stage renal disease.	Am J Med	2002
12160919	Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure.	Journal of Clinical Epidemiology	2002
12152918	Healthcare system interventions for inequality in quality: corrective action through evidence-based medicine.	J Natl Med Assoc	2002
11886309	Does time of day of hemodialysis affect survival?	JAMA - Journal of the American Medical Association	2002
12213139	Preventive health care measures before and after start of renal replacement therapy.	Journal of General Internal Medicine	2002
12082923	Preparing the patient for renal replacement therapy. Teamwork optimizes outcomes.	Postgraduate Medicine	2002
11874596	An introduction to epidemiology and biostatistics and issues in interpretation of studies.	Semin Dial	2002
11812871	Does calcium kill ESRD patients--the skeptic's perspective.	Nephrol Dial Transplant	2002
12138144	National profile of practice patterns for hemodialysis vascular access in the United States.	J Am Soc Nephrol	2002
12358639	Key concepts in biostatistics: using statistics to answer the question "is there a difference?".	Semin Dial	2002
11920346	Comparison of mortality and intermediate outcomes between medicare dialysis patients in HMO and fee for service.	American Journal of Kidney Diseases	2002
12117287	Therapeutic use of the dialysis prescription for improvement in blood pressure control.	International Journal of Artificial Organs	2002
11853068	Peripheral vascular disease and ESRD: what is the most appropriate intervention?	International Journal of Artificial Organs	2002
11157366	Limitations of the facility-specific standardized mortality ratio for profiling health care quality in dialysis.	American Journal of Kidney Diseases	2001
12099224	NKF and RPA collaborating on clinical practice guidelines for chronic kidney disease.	Nephrology news & issues	2001
11455530	Funding ESRD care through charity: the paradigm of the National Kidney Foundation of Singapore.	Seminars in Nephrology	2001